about
Exosome-Mediated Metastasis: From Epithelial-Mesenchymal Transition to Escape from ImmunosurveillancePharmacogenetic versus clinical dosing of warfarin in individuals of Chinese and African-American ancestry: assessment using data simulation.Genetic factors affecting drug disposition in Asian cancer patients.Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.Dose modifications in Asian cancer patients with hepatic dysfunction receiving weekly docetaxel: A prospective pharmacokinetic and safety study.Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursEGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction.Chemotherapy for advanced gastric cancer.Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview.De-novo and acquired resistance to immune checkpoint targeting.Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions.Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.Capecitabine pharmacogenetics: historical milestones and progress toward clinical implementationNordic Walking in Patients with Peripheral Artery DiseaseReal-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" TrialA common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaNon-operative Management of Type A Acute Aortic Syndromes: A Systematic Review and Meta-AnalysisRe: "Open vs Endovascular Repair of Descending Thoracic Aortic Aneurysm Disease: A Systematic Review and Meta-analysis"
P50
Q28275420-ADA1463E-A5E9-48F1-AF17-05E9BD68DE1BQ30984242-71E60C87-278C-49D4-B551-4B5E3594C89AQ34501025-CD207C56-62AD-4A8B-B920-42B1494CBB93Q34529131-D175BFF8-850B-4C15-B54E-D5FF798FECACQ34554505-7BAC2356-FD3F-4E05-A71B-EA2D3DCF208BQ36622084-E56EBE7B-6FA8-49FF-9CF4-B29670A4B15AQ37000818-35DE13D3-8D49-49B9-AC4C-6390FFE0DD6FQ37709182-2602642F-B12E-4DFE-9005-F5CD9D31BE80Q38604012-C206BFEA-873B-4A74-AB94-97E436899455Q39096119-82182460-3D1D-4EE2-8CC6-2D7152FEEC93Q45891664-B459FB56-FE96-486A-81D4-0A3112DEA9E6Q47326952-C0CB38EB-29C5-4716-A720-F76A5B574035Q47757890-1DC123CD-7E18-4C28-85A2-519460B74D99Q48218531-C9334FC3-2BB3-4C63-8739-59E35FB42B66Q88429770-FBFD63BD-66E3-4060-A67F-D174A32CED90Q90225714-9DD77402-8C9F-4E52-A063-E6E98C322855Q90473923-38830CD8-1897-4657-BBB0-A11A11787263Q90664296-BAAF5B5A-4023-4B72-B922-6E475F9A0EDCQ92615442-F9279B5D-A472-4D37-BF6A-D36E7A56574DQ93373629-23D76BB8-5380-43AB-972B-2DA0BE6F0AD3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicholas L Syn
@ast
Nicholas L Syn
@en
Nicholas L Syn
@es
Nicholas L Syn
@nl
type
label
Nicholas L Syn
@ast
Nicholas L Syn
@en
Nicholas L Syn
@es
Nicholas L Syn
@nl
prefLabel
Nicholas L Syn
@ast
Nicholas L Syn
@en
Nicholas L Syn
@es
Nicholas L Syn
@nl
P106
P1153
56857477800
P21
P31
P496
0000-0002-6343-176X